|
|
Committee on
Energy and Commerce
2125 Rayburn House Office
Building, Washington, DC
20515
Phone: (202) 225-2927 Contact Us »
Home »
|
|
|
|
FDA Medical Device Safety
Letters
Feb. 15, 2008 |
Letter to GAO Comptroller General Walker requesting information about the Agency's oversight study of the FDA |
Jan. 18, 2008 |
Letter to McMoran, O'Connor & Bramley, P.C. in regard to decisions made by FDA officials regarding the CYPHER Coronary Stent |
Dec. 13, 2007 |
Letter to HHS Secretary Leavitt in regard to the recently signed Memorandum of Agreements between China and the United States |
Dec. 13, 2007 |
Letter to the Biomedical Research Institute of America and Texas Applied Biomedical Services in regard to the ability of Institutional Review Boards to protect human subjects in biomedical research |
Nov. 26, 2007 |
Letter to Government Accountability Office Comptroller General Walker in regard to the FDA's ability to ensure the safety of medical devices
Dec. 4, 2007 response » |
Nov. 21, 2007 |
Letter to FDA Commissioner von Eschenbach in regard to the ability of Institutional Review Boards to protect human subjects in biomedical research |
Aug. 13, 2007 |
Letter to FDA Commissioner von Eschenbach in regard to the circumstances surrounding an FDA recall letter to to Cordis Corporation about the CYPHER Coronary Stent
May 28, 2008 response »
Jan. 25, 2008 response »
Nov. 27, 2007 response »
Sept. 27, 2007 response »
Sept. 25, 2007 response »
Aug. 16, 2007 response » |
Aug. 13, 2007 |
Letter to Johnson & Johnson CEO Welden in regard to the circumstances surrounding an FDA recall letter to to Cordis Corporation about the CYPHER Coronary Stent
Sept. 4, 2007 response »
|
News Releases
"Dingell, Stupak Comment on FDA Plan for Overseas Inspections" -- January 25, 2008
"Dingell, Stupak Investigating Institutional Review Boards, Questionable Medical Devices" -- December 13, 2007
"FCC Chairman Martin Responds to Letter from Chairman Dingell on Commission Procedures" -- December 11, 2007
|
|